Literature DB >> 18177781

Objective and perspective determine the choice of composite endpoint.

George F Borm1, Steven Teerenstra, Gerhard A Zielhuis.   

Abstract

The most important consideration in the choice of study design and endpoint is that these two features match and represent the objective and the perspective of the trial as closely as possible. The mechanism may also be helpful, but arguments based on the mechanism, structure or levels of the variables, or based on practical considerations, such as (statistical) efficiency, must always be secondary considerations.

Mesh:

Year:  2008        PMID: 18177781     DOI: 10.1016/j.jclinepi.2007.10.001

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.

Authors:  Richard F Potthoff; Susan Halabi
Journal:  Pharm Stat       Date:  2015-04-20       Impact factor: 1.894

2.  Placebo effects and the common cold: a randomized controlled trial.

Authors:  Bruce Barrett; Roger Brown; Dave Rakel; David Rabago; Lucille Marchand; Jo Scheder; Marlon Mundt; Gay Thomas; Shari Barlow
Journal:  Ann Fam Med       Date:  2011 Jul-Aug       Impact factor: 5.166

3.  Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials.

Authors:  Melissa C W Vaanholt; Marlies M Kok; Clemens von Birgelen; Marieke G M Weernink; Janine A van Til
Journal:  Health Expect       Date:  2018-08-14       Impact factor: 3.377

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.